Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy
- PMID: 32703780
- PMCID: PMC7377210
- DOI: 10.1183/13993003.02665-2020
Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy
Abstract
It is important to recognise the impact of COVID-19 on TB care to mitigate its consequences. TB services have an urgent need to identify novel strategies to ensure the continuum of TB care at the time of the coronavirus pandemic. https://bit.ly/2OIKnwL
Conflict of interest statement
Conflict of interest: P. Magro has nothing to disclose. Conflict of interest: B. Formenti has nothing to disclose. Conflict of interest: V. Marchese has nothing to disclose. Conflict of interest: M. Gulletta has nothing to disclose. Conflict of interest: L.R. Tomasoni has nothing to disclose. Conflict of interest: S. Caligaris has nothing to disclose. Conflict of interest: F Castelli reports acting as a principle investigator of company-sponsored clinical trials in the field of HIV infection (ViiV Healthcare, GlaxoSmithKline, Gilead Sciences and Janssen Cilag). Conflict of interest: A. Matteelli has nothing to disclose.
Figures
Comment on
-
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.Eur Respir J. 2020 Jul 9;56(1):2001398. doi: 10.1183/13993003.01398-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32457198 Free PMC article.
-
Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.Eur Respir J. 2020 Jul 30;56(1):2001708. doi: 10.1183/13993003.01708-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32482787 Free PMC article.
References
-
- Dipartimento della Protezione Civile, Data on COVID-19 http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bc.... Date last accessed: 25 June, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous